Detecting HPV DNA in Anal and Cervical Cancers

  • End date
    Nov 15, 2023
  • participants needed
  • sponsor
    University of Chicago
Updated on 23 June 2021
human papillomavirus
diagnostic procedures
human papilloma virus vaccine
human papillomavirus dna


This is a research study for individuals who have cancer associated with human papillomavirus (HPV) and are being treated with radiation as part of standard care for their cancer. Doctors leading this study will use blood tests to find out if they can detect the HPV virus in the blood of study participants before, during, and after radiation treatment. They will also collect blood and archival tumor tissue (from a previous biopsy) to perform other tests in the future that could provide more information about HPV-associated cancers and how they respond to treatment. Participation in this study will last approximately 2 years.

Condition Uterine Serous Carcinoma, Anal Cancer, cervical cancer, uterine, Uterine Cancer, cervical carcinoma, HPV-Related Cervical Carcinoma, anal carcinoma, carcinoma of the cervix uteri, carcinoma of cervix, cancer of the cervix, Rectal Cancer, Cervical Cancer, carcinoma of the cervix, HPV-Related Carcinoma, HPV-Related Anal Squamous Cell Carcinoma, cervix cancer, Disorders of cervix NOS
Treatment Blood sample collection, Physical Exam, Radiation Treatment With or Without Chemotherapy, HPV Genotyping (HPV DNA Test), Testing Archival Tumor Tissue, Positron Emission Tomography Scan (PET Scan)/ Computed Tomography Scan (CT Scan)
Clinical Study IdentifierNCT04857528
SponsorUniversity of Chicago
Last Modified on23 June 2021


Yes No Not Sure

Inclusion Criteria

Stage I-III anal cancer or stage I-IVA cervical cancer that is p16+ based on immunohistochemistry
Age 18 years
Planned to undergo radiation therapy as definitive treatment, with or without concurrent systemic therapy

Exclusion Criteria

Anal carcinoma not associated with HPV-16, 18, 31, 33, or 35 will be removed from the
Planned to undergo radiation therapy as an adjuvant or post-operative therapy
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note